 "Divi's Laboratories")
Drug firm Divi's Laboratories on Saturday reported a 16.71 per cent jump in its consolidated net profit to Rs 606.46 crore for the quarter ended September 30, mainly on account of robust sales.
The company had posted a net profit of Rs 519.59 crore for the corresponding period of the previous fiscal, Divi's Laboratories said in a filing to the BSE.
Its consolidated total income during July-September 2021 stood at Rs 2,006.62 crore. It was Rs 1,762.94 crore in the year-ago period, it added.
The group has not experienced any significant impact on its operations, supply chain and recoverability of carrying amounts of financial and non-financial assets due to the COVID 19 pandemic, Divi's Labs said.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
